Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Selecting the best therapy path for sufferers with myelofibrosis can really feel overwhelming, particularly as new therapies and medical trials proceed to develop,...
Tamron Little was recognized with peritoneal mesothelioma in 2007 as a 21-year-old new mom. Compensate for Tamron's blogs right here!The primary day of fall...
Dr. Joshua Okay. Sabari, a thoracic medical oncologist at NYU Langone Well being’s Perlmutter Most cancers Middle and editor-in-chief of CURE, sat down...
Dr. Prithviraj Bose explains how medical doctors tailor myelofibrosis remedies and the way sufferers can work with their care groups to navigate choices.The...
